Urinary growth hormone estimation in diagnosing severe growth hormone deficiency
- PMID: 8976663
- PMCID: PMC1511705
- DOI: 10.1136/adc.75.3.228
Urinary growth hormone estimation in diagnosing severe growth hormone deficiency
Abstract
Urinary growth hormone was measured in 54 children with short stature who had growth hormone deficiency that was initially diagnosed pharmacologically (arginine and L-dopa) and physiologically (mean growth hormone concentration during sleep evaluated twice). Based on the growth hormone response to pharmacological tests the subjects were subdivided into three groups: group A, 20 subjects with normal response (peak concentration > 8 micrograms/l); group B, 20 subjects with response between 4 and 8 micrograms/l; and group C, 14 subjects with response < 4 micrograms/l. In group A four subjects had an abnormally low nocturnal mean growth hormone concentration (< or = 3.3 micrograms/l). In group C seven subjects had multiple pituitary hormone deficiency and abnormal magnetic resonance imaging. All subjects had urine collected from 8.00 pm to 8.00 am for 4-5 consecutive nights. A positive correlation was found between serum nocturnal mean growth hormone values and urinary growth hormone in all subjects. Mean (SD) concentrations of urinary growth hormone were similar in groups A (18.0 (9.5) ng/g creatinine) and B (13.6 (5.9) ng/g creatinine), but significantly higher than that of group C (3.4 (3.7) ng/g creatinine). Considering as abnormal urinary growth hormones below the lower limit of the range in group A, specificity and sensitivity of urinary growth hormone was 100% and 35% respectively. Sensitivity for groups B and C were 5% and 78% respectively. When considering only the subjects of group C with pathological magnetic resonance findings, sensitivity increased to 100%. In the four subjects of group A with mean growth hormone concentration < or = 3.3 micrograms/l, specificity decreased to 80%. It is concluded that urinary growth hormone assay is characterised by a sensitivity too low to be regarded as improving the traditional diagnostic approach to define growth hormone deficiency, unless it is used to identify subjects with the most severe deficiencies.
Similar articles
-
Nocturnal urinary growth hormone excretion as a criterion for growth hormone deficiency.Braz J Med Biol Res. 1995 Apr;28(4):433-8. Braz J Med Biol Res. 1995. PMID: 8520540
-
A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.J Endocrinol Invest. 1990 Apr;13(4):307-16. doi: 10.1007/BF03349569. J Endocrinol Invest. 1990. PMID: 2115060
-
Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone.Pediatr Res. 1991 Jun;29(6):619-22. doi: 10.1203/00006450-199106010-00019. Pediatr Res. 1991. PMID: 1866220
-
Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient.J Clin Endocrinol Metab. 1994 Dec;79(6):1663-9. doi: 10.1210/jcem.79.6.7989472. J Clin Endocrinol Metab. 1994. PMID: 7989472
-
Current methods for the measurement of growth hormone in urine.Clin Endocrinol (Oxf). 1994 Feb;40(2):155-70. doi: 10.1111/j.1365-2265.1994.tb02462.x. Clin Endocrinol (Oxf). 1994. PMID: 8137512 Review.
Cited by
-
Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.Drug Test Anal. 2009 Sep;1(9-10):447-54. doi: 10.1002/dta.96. Drug Test Anal. 2009. PMID: 20355230 Free PMC article. Review.
-
Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.J Endocrinol Invest. 2001 Jul-Aug;24(7):515-21. doi: 10.1007/BF03343885. J Endocrinol Invest. 2001. PMID: 11508786 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical